Infective Endocarditis: Difference between revisions

Jump to navigation Jump to search
no edit summary
No edit summary
No edit summary
Line 174: Line 174:
#iii  Miró, José M, Ana del Rı́o, and Carlos A Mestres. "Infective endocarditis in intravenous drug abusers and HIV-1 infected patients." Infectious disease clinics of North America 16.2 (2002): 273-295.
#iii  Miró, José M, Ana del Rı́o, and Carlos A Mestres. "Infective endocarditis in intravenous drug abusers and HIV-1 infected patients." Infectious disease clinics of North America 16.2 (2002): 273-295.
#iv Ipek, Esra Gucuk et al. "Infections of implantable cardiac rhythm devices: predisposing factors and outcome." Acta cardiologica 67.3 (2012): 303.
#iv Ipek, Esra Gucuk et al. "Infections of implantable cardiac rhythm devices: predisposing factors and outcome." Acta cardiologica 67.3 (2012): 303.
#v Pappelbaum, Karin I et al. "Ultra-Large von Willebrand Factor Fibers Mediate Luminal Staphylococcus Aureus Adhesion to an Intact Endothelial Cell Layer under Shear Stress." Circulation (2013).
#v pmid=23720451
#vi pmid=21685200
#vi pmid=21685200
#vii Duval, Xavier et al. "Temporal Trends in Infective Endocarditis in the Context of Prophylaxis Guideline ModificationsThree Successive Population-Based Surveys." Journal of the American College of Cardiology 59.22 (2012): 1968-1976.
#vii pmid=22624837
#viii pmid=16028160
#viii pmid=16028160
#ix Rasmussen, Rasmus V et al. "Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography." European Journal of Echocardiography 12.6 (2011): 414-420.
#x pmid=16767483
#x pmid=16767483
#xi pmid=19665088
#xi pmid=19665088
467

edits

Navigation menu